Direkt zum Inhalt
Merck

Topical and systemic therapies for oral and perioral herpes simplex virus infections.

Journal of the California Dental Association (2013-05-28)
Eric T Stoopler, Ramesh Balasubramaniam
ZUSAMMENFASSUNG

Oral and perioral herpes simplex virus (HSV) infections in healthy individuals often present with signs and symptoms that are clearly recognized by oral health care providers (OHCPs). Management of these infections is dependent upon a variety of factors and several agents may be used for treatment to accelerate healing and decrease symptoms associated with lesions. This article will review the pertinent aspects of topical and systemic therapies of HSV infections for the OHCP.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-Valin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Valin, reagent grade, ≥98% (HPLC)
SAFC
L-Valin
Supelco
Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Valin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
2-Aminopurin, ≥99%
Supelco
L-Valin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Valaciclovir -hydrochlorid Hydrat, ≥98% (HPLC), solid
Sigma-Aldrich
Acycloguanosin, ≥99% (HPLC), powder
Aciclovir, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Valin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Famciclovir, ≥98% (HPLC)